Tenelia Elderly CGMS Study(TEDDY)

A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase IV Study to Evaluate the Efficacy and Safety of Tenelia® in Patients Aged 65 and Older With Inadequately Controlled Type 2 Diabetes

To assess the efficacy and safety of Teneligliptin in Patients aged 65 and Older with inadequately controlled type 2 diabetes.

To assess the efficacy and safety of Teneligliptin in Patients aged 65 and Older with inadequately controlled type 2 diabetes.

Inclusion Criteria:

• Patients who are 65 years or older on screening
• Patients with type 2 diabetes mellitus
• Patients with 7.0% ≤ HbA1c ≤ 9.0% at the screening visit
• Patients with FPG < 270mg/dL on screening visit

Exclusion Criteria:

-